# OnCo record nct07227415 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07227415/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07227415", "NCT07227415" ;
  schema:name "Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With "@en ;
  schema:alternateName "Symbiotic-GU-08"@en ;
  schema:description "A phase 1/2 trial of PF-08634404, Ipilimumab, Axitinib in renal cell carcinoma, run by Pfizer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07227415/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07227415> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-02-10" ;
  onco:cancers <https://onco.cc/cancers/rcc/> ;
  onco:drugs <https://onco.cc/drugs/pf-08634404/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/axitinib/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .